Article
Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer
7 Feb 2017
Abstract excerpt
Germline genetic testing of breast cancer patients is an important model of how increasingly widespread genomic sequencing can influence treatment decision-making. Testing of two breast cancer-associated genes, BRCA1/2, has been available for twenty years, but new massively parallel sequencing technology and less restrictive patent laws have made multiplex panel tests available at much lower costs.1 Yet little is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
